
Fact Sheet for Heath Care Providers: Emergency Use Authorization (EUA) of Bamlanivimab
Item
Click for External Resource*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Files for Download

Item Type
GuideTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Document Viewer
Title
Fact Sheet for Heath Care Providers: Emergency Use Authorization (EUA) of Bamlanivimab
Subject
Description
Fact sheet for Bamlanivimab.
EUA: For the treatment of mild-to-moderate COVID-19 in adult and pediatric patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88 pounds), and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
EUA: For the treatment of mild-to-moderate COVID-19 in adult and pediatric patients with positive results of direct SARS-CoV-2 viral testing who are 12 years of age and older weighing at least 40 kilograms (about 88 pounds), and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
Date
2020-11-09
Citation
Download Heathcare Providers Fact Sheet directly: https://www.fda.gov/media/143603/download
Download Patients, Parents, and Caregivers Fact Sheet directly: https://www.fda.gov/media/143604/download
Descargue la hoja de datos de pacientes, padres y cuidadores en español directamente: https://www.fda.gov/media/143645/download
Download the Frequently Asked Questions on the Emergency Use Authorization for Bamlanivimab.
Was this resource helpful?